日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Adjuvant Epirubicin Plus Cyclophosphamide Followed by Taxanes With or Without Carboplatin in Early-Stage Triple-Negative Breast Cancer (RJBC 1501): A Randomized Phase III Trial

早期三阴性乳腺癌辅助化疗方案：表柔比星联合环磷酰胺序贯紫杉烷类药物联合或不联合卡铂（RJBC 1501）：一项随机III期试验

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-02412
Chen, Xiaosong; Huang, Jiahui; Shi, Haoting; Zhu, Juanying; Wu, Weizhu; Ye, Guolin; He, Qi; Shi, Yong; Zhang, Anqin; Xie, Xiaohong; Wang, Xiaodong; Chen, Xiangjing; Wu, Weili; Wu, Jundong; Li, Zhian; Li, Zhanwen; Dai, Yuechu; Ren, Weili; Shao, Qing; Chen, Yongan; Zeng, Yong; Zhang, Fengzhe; Dong, Shuwen; Pegram, Mark Daniel; Shen, Kunwei
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Triple HER2 Blockade With Trastuzumab, Pertuzumab, and Pyrotinib Versus Dual HER2 Blockade in the Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Randomized, Phase II Study

曲妥珠单抗、帕妥珠单抗和吡咯替尼三联HER2阻断疗法与HER2双联阻断疗法在HER2阳性乳腺癌新辅助治疗中的比较：一项随机II期研究

期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70611
Huang, Jiahui; Wang, Haoyu; Tong, Yiwei; Hong, Jin; Zhu, Yifei; Ren, Weili; Yu, Jing; Shi, Haoting; Gao, Weiqi; Zhu, Siji; Wu, Jiayi; Huang, Ou; Li, Jing; He, Jianrong; Chen, Weiguo; Li, Yafen; Shen, Kunwei; Chen, Xiaosong
肿瘤
乳腺癌
肿瘤免疫
HER2
发表日期：2026
文献求助 收藏

Omitting axillary lymph node dissection or not? A multicenter, retrospective study for breast cancer patients potentially eligible for abemaciclib since the SENOMAC trial

是否省略腋窝淋巴结清扫术？一项针对SENOMAC试验后可能符合阿贝西利治疗条件的乳腺癌患者的多中心回顾性研究

期刊:World Journal of Surgical Oncology
影响因子:2.5
doi:10.1186/s12957-026-04260-3
Xu, Zihao; Zeng, Yufei; Shen, Kunwei; Hu, Chao; Gao, Weiqi
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Cancer-associated fibroblast promotes tamoxifen resistance in estrogen receptor positive breast cancer via exosomal LncRNA PRKCQ-AS1/miR-200a-3p/MKP1 axis-mediated apoptosis suppression

癌相关成纤维细胞通过外泌体LncRNA PRKCQ-AS1/miR-200a-3p/MKP1轴介导的细胞凋亡抑制，促进雌激素受体阳性乳腺癌的他莫昔芬耐药性

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03529-x
Wu, Chenghui; Sun, Xi; Lu, Yujie; Wang, Haoyu; Yu, Zhengyuan; Wang, Zheng; Huang, Renhong; Jin, Yihua; Chen, Xing; Xie, Haixia; Zong, Yu; Shen, Kunwei; Jiang, Min; Tang, Yujie; Chen, Xiaosong
外泌体
成纤维细胞
肿瘤
凋亡
表观遗传
肿瘤免疫
信号转导
乳腺癌
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Development and validation of prognostic model based on distribution and density of CD3(+) and CD8(+) infiltrating lymphocytes in breast cancer: A multicenter cohort study.

基于乳腺癌中 CD3(+) 和 CD8(+) 浸润淋巴细胞的分布和密度的预后模型的开发和验证：一项多中心队列研究。

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2025.104632
Zhang Xu, Wang Zheng, Tong Yiwei, Sun Xi, Gao Weiqi, Fei Xiaocun, Tang Yujie, Zhu Juanying, Li Zhi'an, Shen Kunwei, Chen Xiaosong
乳腺癌
细胞生物学
T细胞
CD8
CD3
发表日期：2025
文献求助 收藏

A pyrimidine metabolism-related gene signature for prognosis prediction and immune microenvironment description of breast cancer

嘧啶代谢相关基因特征用于乳腺癌预后预测和免疫微环境描述

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-06700-2
Wang, Han; Zhou, Ziling; Zhong, Hanyi; Wang, Shoutang; Shen, Kunwei; Huang, Renhong; Wang, Ruo; Wang, Zheng
肿瘤
肿瘤免疫
乳腺癌
代谢
免疫/内分泌
发表日期：2025
文献求助 收藏

Carboplatin-resistance-related DNA damage repair prognostic gene signature and its association with immune infiltration in breast cancer.

卡铂耐药相关DNA损伤修复预后基因特征及其与乳腺癌免疫浸润的关系

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1522149
Dong Shuwen, Li Anqi, Pan Ruixin, Hong Jin, Wang Zheng, Shen Kunwei
肿瘤
乳腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Integrating genomic mutations and tumor-infiltrating lymphocytes improves prediction of response to trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer

整合基因组突变和肿瘤浸润淋巴细胞可提高对HER2阳性乳腺癌患者曲妥珠单抗辅助治疗疗效的预测准确性

期刊:Cancer Drug Resistance
影响因子:5.2
doi:10.20517/cdr.2025.133
Lu, Shuangshuang; Zhang, Yuliang; Tong, Yiwei; Shu, Lan; Huang, Renhong; Gu, Yijin; Wang, Chaofu; Li, Jianfeng; Shen, Kunwei; Dong, Lei; Chen, Xiaosong
肿瘤
HER2
肿瘤免疫
乳腺癌
细胞生物学
发表日期：2025
文献求助 收藏

Clinicopathological and molecular significance of HER2-low expression in Asian women with triple-negative breast cancer

HER2低表达在亚洲三阴性乳腺癌女性中的临床病理学和分子意义

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251353083
Yang, Cuiyan; Wang, Haoyu; Tong, Yiwei; Wang, Zheng; Sun, Xi; Li, Anqi; Lu, Yujie; Han, Mengyuan; Zhu, Siji; Dong, Lei; Shen, Kunwei; Chen, Xiaosong
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Development and validation of a postoperative prognostic model for hormone receptor positive early stage breast cancer recurrence

建立和验证激素受体阳性早期乳腺癌复发的术后预后模型

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-92872-2
Pan, Ruixin; Shi, Haoting; Shen, Yiqing; Wang, Xue; Zhao, Shi; Zhang, Nan; Zhang, Xueyan; Dong, Shuwen; Hu, Chao; Wu, Jiayi; Chai, Weimin; Chen, Xiaosong; Shen, Kunwei
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏